Codes / ICD10CM / E11.34

E11.34 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy

Summary

Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy is a condition where chronic high blood sugar levels cause significant damage to the retinal blood vessels, leading to advanced retinal changes without new blood vessel growth (proliferation). This stage is characterized by widespread retinal ischemia, intraretinal microvascular abnormalities, and venous beading. While vision may not be severely impaired at this stage, the risk of progression to proliferative diabetic retinopathy or vision-threatening complications is high if not managed appropriately.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, leading to severe nonproliferative diabetic retinopathy. Prolonged hyperglycemia in type 2 diabetes triggers vascular changes, including capillary closure and retinal ischemia. Metabolic factors associated with diabetes, such as advanced glycation end products and oxidative stress, contribute to this ocular complication. Insulin resistance or insufficient insulin production in type 2 diabetes sustains hyperglycemia, accelerating retinal damage.

Risk Factors

  • Poorly controlled blood glucose levels.
  • Long duration of diabetes.
  • Hypertension and dyslipidemia.
  • Smoking.
  • Obesity and sedentary lifestyle.

Symptoms

  • Blurred or distorted vision.
  • Increased floaters or spots in the visual field.
  • Difficulty with night vision or color perception.
  • Reduced visual acuity in advanced cases.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal evaluation, optical coherence tomography (OCT), and fluorescein angiography to assess retinal health. Blood glucose and HbA1c levels are measured to confirm diabetes control. Fundus photography may document retinal changes, such as intraretinal microvascular abnormalities, venous beading, or extensive hemorrhages.

Treatment Options

  • Intensive blood sugar management through medication, diet, and exercise.
  • Blood pressure and lipid control to reduce vascular risk.
  • Regular eye examinations to monitor progression.
  • Referral to a retina specialist for advanced imaging or potential intervention.

Prognosis and Follow-Up

With proper management, progression to proliferative diabetic retinopathy or vision loss may be slowed. However, severe nonproliferative diabetic retinopathy carries a higher risk of complications. Follow-up eye exams are critical, typically every 3–6 months, to detect early signs of progression. Laser therapy or anti-VEGF injections may be considered if high-risk features develop.

Complications

  • Progression to proliferative diabetic retinopathy, increasing the risk of vitreous hemorrhage or retinal detachment.
  • Macular edema, leading to central vision loss.
  • Vision impairment or blindness if untreated.

Lifestyle & Prevention

  • Maintain tight glycemic control to reduce retinal damage.
  • Manage blood pressure and cholesterol levels.
  • Avoid smoking and limit alcohol intake.
  • Engage in regular physical activity and a balanced diet.
  • Attend routine eye screenings as recommended by a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain, as these may indicate progression to a vision-threatening condition. Regular follow-up with an ophthalmologist is essential for monitoring and early intervention.

Tips for Medical Coders

Document the presence of severe nonproliferative diabetic retinopathy with supporting clinical findings, such as retinal imaging or specialist evaluation. Ensure the code is used only when the retinopathy is classified as severe (e.g., extensive intraretinal microvascular abnormalities, venous beading) and not for milder or unspecified stages. Include details on diabetes management and any related ophthalmic interventions to support accurate coding.

Book a walkthrough

E11.34 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.